There are a few studies regarding the expression and role of COL6A1 in human malignancies, although high expression of COL6A1 observed in prostate cancer, renal cell carcinoma, and cervical cancer was associated with poor survival outcome 7-9. This evidence concerns the gene COL6A1 and prostate carcinoma.